HEADER TRANSFERASE/INHIBITOR 26-SEP-23 8UCC TITLE IRAK4 IN COMPLEX WITH COMPOUND 20 COMPND MOL_ID: 1; COMPND 2 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: KINASE DOMAIN; COMPND 5 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 6 EC: 2.7.11.1; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: INTERLEUKIN-1 RECEPTOR-ASSOCIATED KINASE 4; COMPND 10 CHAIN: B; COMPND 11 FRAGMENT: KINASE DOMAIN; COMPND 12 SYNONYM: IRAK-4,RENAL CARCINOMA ANTIGEN NY-REN-64; COMPND 13 EC: 2.7.11.1; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: IRAK4; SOURCE 6 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 7111; SOURCE 8 MOL_ID: 2; SOURCE 9 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 10 ORGANISM_COMMON: HUMAN; SOURCE 11 ORGANISM_TAXID: 9606; SOURCE 12 GENE: IRAK4; SOURCE 13 EXPRESSION_SYSTEM: TRICHOPLUSIA NI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 7111 KEYWDS KINASE, TRANSFERASE, TRANSFERASE-INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR C.M.METRICK,J.V.CHODAPARAMBIL REVDAT 2 16-OCT-24 8UCC 1 REMARK REVDAT 1 26-JUN-24 8UCC 0 JRNL AUTH R.EVANS,P.N.BOLDUC,M.PFAFFENBACH,F.GAO,T.MAY-DRACKA,T.FANG, JRNL AUTH 2 B.T.HOPKINS,J.V.CHODAPARAMBIL,K.L.HENRY,P.LI,C.METRICK, JRNL AUTH 3 A.NELSON,P.TRAPA,A.THOMAS,L.BURKLY,E.A.PETERSON JRNL TITL THE DISCOVERY OF JRNL TITL 2 7-ISOPROPOXY-2-(1-METHYL-2-OXABICYCLO[2.1.1]HEXAN-4-YL)- N JRNL TITL 3 -(6-METHYLPYRAZOLO[1,5- A ]PYRIMIDIN-3-YL)IMIDAZO[1,2- A JRNL TITL 4 ]PYRIMIDINE-6-CARBOXAMIDE (BIO-7488), A POTENT, SELECTIVE, JRNL TITL 5 AND CNS-PENETRANT IRAK4 INHIBITOR FOR THE TREATMENT OF JRNL TITL 6 ISCHEMIC STROKE. JRNL REF J.MED.CHEM. V. 67 4676 2024 JRNL REFN ISSN 0022-2623 JRNL PMID 38467640 JRNL DOI 10.1021/ACS.JMEDCHEM.3C02226 REMARK 2 REMARK 2 RESOLUTION. 1.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX 1.20.1_4487 REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : GEOSTD + MONOMER LIBRARY + CDL V1.2 REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 31.99 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 1.340 REMARK 3 COMPLETENESS FOR RANGE (%) : 99.8 REMARK 3 NUMBER OF REFLECTIONS : 68020 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.210 REMARK 3 R VALUE (WORKING SET) : 0.208 REMARK 3 FREE R VALUE : 0.240 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 4.960 REMARK 3 FREE R VALUE TEST SET COUNT : 3373 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 31.9900 - 5.1900 1.00 2865 146 0.1904 0.1962 REMARK 3 2 5.1800 - 4.1200 0.99 2770 135 0.1633 0.2118 REMARK 3 3 4.1200 - 3.6000 1.00 2736 132 0.1734 0.1789 REMARK 3 4 3.6000 - 3.2700 1.00 2695 147 0.1968 0.2220 REMARK 3 5 3.2700 - 3.0400 0.99 2720 148 0.2145 0.2424 REMARK 3 6 3.0400 - 2.8600 1.00 2694 138 0.2229 0.2646 REMARK 3 7 2.8600 - 2.7100 1.00 2729 125 0.2303 0.2879 REMARK 3 8 2.7100 - 2.6000 1.00 2669 151 0.2242 0.2649 REMARK 3 9 2.6000 - 2.5000 1.00 2675 157 0.2264 0.2715 REMARK 3 10 2.5000 - 2.4100 1.00 2696 125 0.2105 0.2275 REMARK 3 11 2.4100 - 2.3300 1.00 2682 147 0.2202 0.2884 REMARK 3 12 2.3300 - 2.2700 1.00 2670 137 0.2201 0.2616 REMARK 3 13 2.2700 - 2.2100 1.00 2673 148 0.2153 0.2718 REMARK 3 14 2.2100 - 2.1500 1.00 2655 154 0.2144 0.2299 REMARK 3 15 2.1500 - 2.1100 1.00 2672 148 0.2355 0.2891 REMARK 3 16 2.1100 - 2.0600 1.00 2685 135 0.2467 0.2968 REMARK 3 17 2.0600 - 2.0200 1.00 2685 117 0.2608 0.2798 REMARK 3 18 2.0200 - 1.9800 1.00 2697 144 0.2575 0.2893 REMARK 3 19 1.9800 - 1.9500 1.00 2643 133 0.2610 0.3163 REMARK 3 20 1.9500 - 1.9100 1.00 2689 137 0.2684 0.2969 REMARK 3 21 1.9100 - 1.8800 1.00 2645 131 0.3013 0.3350 REMARK 3 22 1.8800 - 1.8500 1.00 2664 144 0.3202 0.3307 REMARK 3 23 1.8500 - 1.8300 1.00 2679 142 0.3563 0.3961 REMARK 3 24 1.8300 - 1.8000 1.00 2659 152 0.3648 0.4328 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.10 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : NULL REMARK 3 B_SOL : NULL REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.265 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 27.345 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 32.06 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 42.78 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.014 4546 REMARK 3 ANGLE : 1.341 6179 REMARK 3 CHIRALITY : 0.082 709 REMARK 3 PLANARITY : 0.011 790 REMARK 3 DIHEDRAL : 14.210 1669 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 8UCC COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 09-OCT-23. REMARK 100 THE DEPOSITION ID IS D_1000277552. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 17-JUL-20 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SLS REMARK 200 BEAMLINE : X06SA REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : PIXEL REMARK 200 DETECTOR MANUFACTURER : DECTRIS EIGER X 1M REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XDS REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 68053 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.800 REMARK 200 RESOLUTION RANGE LOW (A) : 90.240 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : NULL REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.9 REMARK 200 DATA REDUNDANCY : 6.600 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 16.7000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 1.80 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 1.84 REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHENIX REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 56.08 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.80 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: SODIUM MALONATE, VAPOR DIFFUSION, REMARK 280 TEMPERATURE 293K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: I 2 2 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z REMARK 290 3555 -X,Y,-Z REMARK 290 4555 X,-Y,-Z REMARK 290 5555 X+1/2,Y+1/2,Z+1/2 REMARK 290 6555 -X+1/2,-Y+1/2,Z+1/2 REMARK 290 7555 -X+1/2,Y+1/2,-Z+1/2 REMARK 290 8555 X+1/2,-Y+1/2,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 5 1.000000 0.000000 0.000000 44.31600 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 59.01250 REMARK 290 SMTRY3 5 0.000000 0.000000 1.000000 70.00850 REMARK 290 SMTRY1 6 -1.000000 0.000000 0.000000 44.31600 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 59.01250 REMARK 290 SMTRY3 6 0.000000 0.000000 1.000000 70.00850 REMARK 290 SMTRY1 7 -1.000000 0.000000 0.000000 44.31600 REMARK 290 SMTRY2 7 0.000000 1.000000 0.000000 59.01250 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 70.00850 REMARK 290 SMTRY1 8 1.000000 0.000000 0.000000 44.31600 REMARK 290 SMTRY2 8 0.000000 -1.000000 0.000000 59.01250 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 70.00850 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLU A 154 REMARK 465 ASN A 155 REMARK 465 LYS A 156 REMARK 465 SER A 157 REMARK 465 LEU A 158 REMARK 465 GLU A 159 REMARK 465 GLU A 337 REMARK 465 LYS A 338 REMARK 465 PHE A 339 REMARK 465 ALA A 340 REMARK 465 GLN A 341 REMARK 465 SER A 460 REMARK 465 GLU B 154 REMARK 465 ASN B 155 REMARK 465 LYS B 156 REMARK 465 SER B 157 REMARK 465 LEU B 158 REMARK 465 GLU B 159 REMARK 465 VAL B 160 REMARK 465 SER B 161 REMARK 465 ASP B 162 REMARK 465 THR B 163 REMARK 465 ALA B 217 REMARK 465 MET B 218 REMARK 465 VAL B 219 REMARK 465 ASP B 220 REMARK 465 GLU B 337 REMARK 465 LYS B 338 REMARK 465 PHE B 339 REMARK 465 ALA B 340 REMARK 465 GLN B 341 REMARK 465 ALA B 459 REMARK 465 SER B 460 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 160 CG1 CG2 REMARK 470 SER A 161 OG REMARK 470 ASP A 162 CG OD1 OD2 REMARK 470 ARG A 164 CG CD NE CZ NH1 NH2 REMARK 470 ASN A 206 CG OD1 ND2 REMARK 470 VAL A 219 CG1 CG2 REMARK 470 ASP A 220 CG OD1 OD2 REMARK 470 GLU A 224 CG CD OE1 OE2 REMARK 470 GLU A 225 CG CD OE1 OE2 REMARK 470 GLN A 228 CG CD OE1 NE2 REMARK 470 LYS A 235 CG CD CE NZ REMARK 470 LYS A 239 CG CD CE NZ REMARK 470 ASP A 256 CG OD1 OD2 REMARK 470 THR A 342 OG1 CG2 REMARK 470 SEP A 346 OG P O1P O2P O3P REMARK 470 ARG A 347 CG CD NE CZ NH1 NH2 REMARK 470 LYS A 441 CG CD CE NZ REMARK 470 LYS A 443 CG CD CE NZ REMARK 470 GLN A 455 CG CD OE1 NE2 REMARK 470 ARG B 164 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 172 CG CD OE1 OE2 REMARK 470 LYS B 174 CG CD CE NZ REMARK 470 ASN B 175 CG OD1 ND2 REMARK 470 ILE B 221 CG1 CG2 CD1 REMARK 470 THR B 222 OG1 CG2 REMARK 470 GLU B 224 CG CD OE1 OE2 REMARK 470 GLU B 225 CG CD OE1 OE2 REMARK 470 LYS B 235 CG CD CE NZ REMARK 470 LYS B 239 CG CD CE NZ REMARK 470 LYS B 290 CG CD CE NZ REMARK 470 GLU B 321 CG CD OE1 OE2 REMARK 470 THR B 342 OG1 CG2 REMARK 470 ARG B 347 CG CD NE CZ NH1 NH2 REMARK 470 GLU B 389 CG CD OE1 OE2 REMARK 470 GLU B 392 CG CD OE1 OE2 REMARK 470 LEU B 397 CG CD1 CD2 REMARK 470 GLU B 401 CG CD OE1 OE2 REMARK 470 GLU B 404 CG CD OE1 OE2 REMARK 470 GLU B 406 CG CD OE1 OE2 REMARK 470 GLU B 407 CG CD OE1 OE2 REMARK 470 LYS B 408 CG CD CE NZ REMARK 470 HIS B 438 CG ND1 CD2 CE1 NE2 REMARK 470 GLU B 439 CG CD OE1 OE2 REMARK 470 LYS B 440 CG CD CE NZ REMARK 470 LYS B 441 CG CD CE NZ REMARK 470 LYS B 443 CG CD CE NZ REMARK 470 ASP B 446 CG OD1 OD2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 162 -128.25 71.25 REMARK 500 ARG A 310 -4.78 77.10 REMARK 500 ASP A 311 45.48 -142.72 REMARK 500 ASP A 329 75.99 66.11 REMARK 500 GLU A 406 16.80 53.89 REMARK 500 ASN B 206 -108.63 55.44 REMARK 500 ARG B 310 -4.06 77.72 REMARK 500 ASP B 311 48.40 -144.80 REMARK 500 ASP B 329 79.94 70.33 REMARK 500 GLU B 406 16.61 51.51 REMARK 500 LYS B 417 42.82 -86.51 REMARK 500 REMARK 500 REMARK: NULL REMARK 525 REMARK 525 SOLVENT REMARK 525 REMARK 525 THE SOLVENT MOLECULES HAVE CHAIN IDENTIFIERS THAT REMARK 525 INDICATE THE POLYMER CHAIN WITH WHICH THEY ARE MOST REMARK 525 CLOSELY ASSOCIATED. THE REMARK LISTS ALL THE SOLVENT REMARK 525 MOLECULES WHICH ARE MORE THAN 5A AWAY FROM THE REMARK 525 NEAREST POLYMER CHAIN (M = MODEL NUMBER; REMARK 525 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE REMARK 525 NUMBER; I=INSERTION CODE): REMARK 525 REMARK 525 M RES CSSEQI REMARK 525 HOH B 701 DISTANCE = 6.49 ANGSTROMS REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 8UCB RELATED DB: PDB DBREF 8UCC A 154 460 UNP Q9NWZ3 IRAK4_HUMAN 154 460 DBREF 8UCC B 154 460 UNP Q9NWZ3 IRAK4_HUMAN 154 460 SEQRES 1 A 307 GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE HIS SEQRES 2 A 307 SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN SEQRES 3 A 307 PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET SEQRES 4 A 307 GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL SEQRES 5 A 307 ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET SEQRES 6 A 307 VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP SEQRES 7 A 307 GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN SEQRES 8 A 307 LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP SEQRES 9 A 307 LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU SEQRES 10 A 307 LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SEQRES 11 A 307 SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA SEQRES 12 A 307 ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS SEQRES 13 A 307 ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA SEQRES 14 A 307 PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SEQRES 15 A 307 SER GLU LYS PHE ALA GLN THR VAL MET TPO SEP ARG ILE SEQRES 16 A 307 VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG SEQRES 17 A 307 GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY SEQRES 18 A 307 VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL SEQRES 19 A 307 ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS SEQRES 20 A 307 GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR SEQRES 21 A 307 ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER VAL SEQRES 22 A 307 GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU SEQRES 23 A 307 LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN SEQRES 24 A 307 LEU LEU GLN GLU MET THR ALA SER SEQRES 1 B 307 GLU ASN LYS SER LEU GLU VAL SER ASP THR ARG PHE HIS SEQRES 2 B 307 SER PHE SER PHE TYR GLU LEU LYS ASN VAL THR ASN ASN SEQRES 3 B 307 PHE ASP GLU ARG PRO ILE SER VAL GLY GLY ASN LYS MET SEQRES 4 B 307 GLY GLU GLY GLY PHE GLY VAL VAL TYR LYS GLY TYR VAL SEQRES 5 B 307 ASN ASN THR THR VAL ALA VAL LYS LYS LEU ALA ALA MET SEQRES 6 B 307 VAL ASP ILE THR THR GLU GLU LEU LYS GLN GLN PHE ASP SEQRES 7 B 307 GLN GLU ILE LYS VAL MET ALA LYS CYS GLN HIS GLU ASN SEQRES 8 B 307 LEU VAL GLU LEU LEU GLY PHE SER SER ASP GLY ASP ASP SEQRES 9 B 307 LEU CYS LEU VAL TYR VAL TYR MET PRO ASN GLY SER LEU SEQRES 10 B 307 LEU ASP ARG LEU SER CYS LEU ASP GLY THR PRO PRO LEU SEQRES 11 B 307 SER TRP HIS MET ARG CYS LYS ILE ALA GLN GLY ALA ALA SEQRES 12 B 307 ASN GLY ILE ASN PHE LEU HIS GLU ASN HIS HIS ILE HIS SEQRES 13 B 307 ARG ASP ILE LYS SER ALA ASN ILE LEU LEU ASP GLU ALA SEQRES 14 B 307 PHE THR ALA LYS ILE SER ASP PHE GLY LEU ALA ARG ALA SEQRES 15 B 307 SER GLU LYS PHE ALA GLN THR VAL MET TPO SER ARG ILE SEQRES 16 B 307 VAL GLY THR THR ALA TYR MET ALA PRO GLU ALA LEU ARG SEQRES 17 B 307 GLY GLU ILE THR PRO LYS SER ASP ILE TYR SER PHE GLY SEQRES 18 B 307 VAL VAL LEU LEU GLU ILE ILE THR GLY LEU PRO ALA VAL SEQRES 19 B 307 ASP GLU HIS ARG GLU PRO GLN LEU LEU LEU ASP ILE LYS SEQRES 20 B 307 GLU GLU ILE GLU ASP GLU GLU LYS THR ILE GLU ASP TYR SEQRES 21 B 307 ILE ASP LYS LYS MET ASN ASP ALA ASP SER THR SER VAL SEQRES 22 B 307 GLU ALA MET TYR SER VAL ALA SER GLN CYS LEU HIS GLU SEQRES 23 B 307 LYS LYS ASN LYS ARG PRO ASP ILE LYS LYS VAL GLN GLN SEQRES 24 B 307 LEU LEU GLN GLU MET THR ALA SER MODRES 8UCC TPO A 345 THR MODIFIED RESIDUE MODRES 8UCC SEP A 346 SER MODIFIED RESIDUE MODRES 8UCC TPO B 345 THR MODIFIED RESIDUE HET TPO A 345 11 HET SEP A 346 5 HET TPO B 345 11 HET WFQ A 501 33 HET WFQ B 501 33 HETNAM TPO PHOSPHOTHREONINE HETNAM SEP PHOSPHOSERINE HETNAM WFQ (4S)-2-[(1R,4S)-1-METHYL-2-OXABICYCLO[2.1.1]HEXAN-4- HETNAM 2 WFQ YL]-N-[(8S)-6-METHYLPYRAZOLO[1,5-A]PYRIMIDIN-3-YL]-7- HETNAM 3 WFQ [(PROPAN-2-YL)OXY]IMIDAZO[1,2-A]PYRIMIDINE-6- HETNAM 4 WFQ CARBOXAMIDE HETSYN TPO PHOSPHONOTHREONINE HETSYN SEP PHOSPHONOSERINE FORMUL 1 TPO 2(C4 H10 N O6 P) FORMUL 1 SEP C3 H8 N O6 P FORMUL 3 WFQ 2(C23 H25 N7 O3) FORMUL 5 HOH *186(H2 O) HELIX 1 AA1 SER A 169 THR A 177 1 9 HELIX 2 AA2 PRO A 184 GLY A 188 5 5 HELIX 3 AA3 THR A 222 CYS A 240 1 19 HELIX 4 AA4 SER A 269 SER A 275 1 7 HELIX 5 AA5 CYS A 276 THR A 280 5 5 HELIX 6 AA6 SER A 284 ASN A 305 1 22 HELIX 7 AA7 LYS A 313 ALA A 315 5 3 HELIX 8 AA8 THR A 351 MET A 355 5 5 HELIX 9 AA9 ALA A 356 ARG A 361 1 6 HELIX 10 AB1 PRO A 366 GLY A 383 1 18 HELIX 11 AB2 LEU A 396 ASP A 405 1 10 HELIX 12 AB3 THR A 409 ILE A 414 1 6 HELIX 13 AB4 ASP A 422 LEU A 437 1 16 HELIX 14 AB5 LYS A 440 ARG A 444 5 5 HELIX 15 AB6 ASP A 446 THR A 458 1 13 HELIX 16 AB7 SER B 169 THR B 177 1 9 HELIX 17 AB8 PRO B 184 GLY B 188 5 5 HELIX 18 AB9 THR B 222 CYS B 240 1 19 HELIX 19 AC1 SER B 269 SER B 275 1 7 HELIX 20 AC2 CYS B 276 THR B 280 5 5 HELIX 21 AC3 SER B 284 ASN B 305 1 22 HELIX 22 AC4 LYS B 313 ALA B 315 5 3 HELIX 23 AC5 THR B 351 MET B 355 5 5 HELIX 24 AC6 ALA B 356 ARG B 361 1 6 HELIX 25 AC7 THR B 365 GLY B 383 1 19 HELIX 26 AC8 LEU B 397 ASP B 405 1 9 HELIX 27 AC9 THR B 409 ILE B 414 1 6 HELIX 28 AD1 ASP B 422 LEU B 437 1 16 HELIX 29 AD2 LYS B 440 ARG B 444 5 5 HELIX 30 AD3 ASP B 446 THR B 458 1 13 SHEET 1 AA1 6 HIS A 166 SER A 167 0 SHEET 2 AA1 6 LEU A 248 SER A 252 1 O PHE A 251 N HIS A 166 SHEET 3 AA1 6 CYS A 259 VAL A 263 -1 O VAL A 261 N LEU A 249 SHEET 4 AA1 6 THR A 208 LEU A 215 -1 N LYS A 213 O LEU A 260 SHEET 5 AA1 6 GLY A 198 VAL A 205 -1 N TYR A 201 O VAL A 212 SHEET 6 AA1 6 LYS A 191 GLY A 195 -1 N GLY A 195 O GLY A 198 SHEET 1 AA2 2 HIS A 307 ILE A 308 0 SHEET 2 AA2 2 ARG A 334 ALA A 335 -1 O ARG A 334 N ILE A 308 SHEET 1 AA3 2 ILE A 317 LEU A 319 0 SHEET 2 AA3 2 ALA A 325 ILE A 327 -1 O LYS A 326 N LEU A 318 SHEET 1 AA4 2 VAL A 343 MET A 344 0 SHEET 2 AA4 2 GLU A 363 ILE A 364 -1 O ILE A 364 N VAL A 343 SHEET 1 AA5 6 HIS B 166 PHE B 168 0 SHEET 2 AA5 6 LEU B 248 SER B 252 1 O PHE B 251 N PHE B 168 SHEET 3 AA5 6 CYS B 259 VAL B 263 -1 O VAL B 261 N LEU B 249 SHEET 4 AA5 6 THR B 208 LEU B 215 -1 N LYS B 213 O LEU B 260 SHEET 5 AA5 6 GLY B 198 VAL B 205 -1 N TYR B 201 O VAL B 212 SHEET 6 AA5 6 LYS B 191 GLU B 194 -1 N MET B 192 O VAL B 200 SHEET 1 AA6 2 HIS B 307 ILE B 308 0 SHEET 2 AA6 2 ARG B 334 ALA B 335 -1 O ARG B 334 N ILE B 308 SHEET 1 AA7 2 ILE B 317 LEU B 319 0 SHEET 2 AA7 2 ALA B 325 ILE B 327 -1 O LYS B 326 N LEU B 318 SHEET 1 AA8 2 VAL B 343 MET B 344 0 SHEET 2 AA8 2 GLU B 363 ILE B 364 -1 O ILE B 364 N VAL B 343 LINK C MET A 344 N TPO A 345 1555 1555 1.33 LINK C TPO A 345 N SEP A 346 1555 1555 1.33 LINK C SEP A 346 N ARG A 347 1555 1555 1.34 LINK C MET B 344 N TPO B 345 1555 1555 1.34 LINK C TPO B 345 N SER B 346 1555 1555 1.34 CISPEP 1 GLU A 392 PRO A 393 0 -3.69 CISPEP 2 GLU B 392 PRO B 393 0 -6.35 CRYST1 88.632 118.025 140.017 90.00 90.00 90.00 I 2 2 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011283 0.000000 0.000000 0.00000 SCALE2 0.000000 0.008473 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007142 0.00000